Global Iron Chelation Drug Market Status and Outlook 2018-2025

July 2018 | 167 pages | ID: G528777C324EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Apotex Inc. (Canada)
• Cipla (India)
• Novartis (Switzerland)
• Sun Pharma (India)
• Natco Pharma (India)

Market by Type

• Deferoxamine
• Deferiprone
• Deferasirox

Market by Application

• Transfusional Iron Overload
• NTDT Caused Iron Overload

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Iron Chelation Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Deferoxamine
  3.1.2 Deferiprone
  3.1.3 Deferasirox
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Transfusional Iron Overload
  4.1.2 NTDT Caused Iron Overload
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Deferoxamine Production by Region
    6.1.1.2 Deferiprone Production by Region
    6.1.1.3 Deferasirox Production by Region
  6.1.2 Production by Application
    6.1.2.1 Transfusional Iron Overload Production by Region
    6.1.2.2 NTDT Caused Iron Overload Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Deferoxamine Demand by Region
    6.2.1.2 Deferiprone Demand by Region
    6.2.1.3 Deferasirox Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Transfusional Iron Overload Demand by Region
    6.2.2.2 NTDT Caused Iron Overload Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Apotex Inc. (Canada)
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Cipla (India)
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Novartis (Switzerland)
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Sun Pharma (India)
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Natco Pharma (India)
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Iron Chelation Drug Industry Dynamics & Regulations List
Table Global Iron Chelation Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Iron Chelation Drug Market Status by Type 2015-2018E, in USD Million
Table Global Iron Chelation Drug Market Status by Application 2015-2018E, in USD Million
Table Global Iron Chelation Drug Market Status by Application 2015-2018E, in Volume
Table Global Iron Chelation Drug Market by Region 2015-2018E, in USD Million
Table Global Iron Chelation Drug Market Share by Region in 2018, in USD Million
Table Global Iron Chelation Drug Market by Region 2015-2018E, in Volume
Table Global Iron Chelation Drug Market Share by Region in 2018, in Volume
Table Deferoxamine Production Value by Region 2015-2018E, in USD Million
Table Deferoxamine Production Volume by Region 2015-2018E, in Volume
Table Deferiprone Production Value by Region 2015-2018E, in USD Million
Table Deferiprone Production Volume by Region 2015-2018E, in Volume
Table Deferasirox Production Value by Region 2015-2018E, in USD Million
Table Deferasirox Production Volume by Region 2015-2018E, in Volume
Table Transfusional Iron Overload Production Value by Region 2015-2018E, in USD Million
Table Transfusional Iron Overload Production Volume by Region 2015-2018E, in Volume
Table NTDT Caused Iron Overload Production Value by Region 2015-2018E, in USD Million
Table NTDT Caused Iron Overload Production Volume by Region 2015-2018E, in Volume
Table Deferoxamine Market Size by Region 2015-2018E, in USD Million
Table Deferoxamine Market Size by Region 2015-2018E, in Volume
Table Deferiprone Market Size by Region 2015-2018E, in USD Million
Table Deferiprone Market Size by Region 2015-2018E, in Volume
Table Deferasirox Market Size by Region 2015-2018E, in USD Million
Table Deferasirox Market Size by Region 2015-2018E, in Volume
Table Transfusional Iron Overload Market Size by Region 2015-2018E, in USD Million
Table Transfusional Iron Overload Market Size by Region 2015-2018E, in Volume
Table NTDT Caused Iron Overload Market Size by Region 2015-2018E, in USD Million
Table NTDT Caused Iron Overload Market Size by Region 2015-2018E, in Volume
Table GlobalIron Chelation Drug Forecast by Type 2019F-2025F, in USD Million
Table Iron Chelation Drug Forecast by Type 2019F-2025F, in Volume
Table Iron Chelation Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Iron Chelation Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Iron Chelation Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Iron Chelation Drug Market Forecast by Region 2019F-2025F, in Volume
Table Apotex Inc. (Canada) Information
Table Iron Chelation Drug Sales, Cost, Margin of Apotex Inc. (Canada)
Table Cipla (India) Information
Table Iron Chelation Drug Sales, Cost, Margin of Cipla (India)
Table Novartis (Switzerland) Information
Table Iron Chelation Drug Sales, Cost, Margin of Novartis (Switzerland)
Table Sun Pharma (India) Information
Table Iron Chelation Drug Sales, Cost, Margin of Sun Pharma (India)
Table Natco Pharma (India) Information
Table Iron Chelation Drug Sales, Cost, Margin of Natco Pharma (India)
Table Global Iron Chelation Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Iron Chelation Drug Sales Volume by Company 2015-2017, in Volume
Table Global Iron Chelation Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Iron Chelation Drug Picture
Figure Iron Chelation Drug Industry Chain Diagram
Figure Global Iron Chelation Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Iron Chelation Drug Sales Volume 2015-2018E, in Volume
Figure Global Iron Chelation Drug Market Status by Type 2015-2018E, in Volume
Figure North America Iron Chelation Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Iron Chelation Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Iron Chelation Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Iron Chelation Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Iron Chelation Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Iron Chelation Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Iron Chelation Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Iron Chelation Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Iron Chelation Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Iron Chelation Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Iron Chelation Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Iron Chelation Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Iron Chelation Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Iron Chelation Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Iron Chelation Drug Sales Price Forecast 2019F-2025F
Figure Global Iron Chelation Drug Gross Margin Forecast 2019F-2025F
Figure Global Iron Chelation Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Iron Chelation Drug Price by Company in 2018
Figure Global Iron Chelation Drug Gross Margin by Company in 2018